SCHEMBL12943462

SCHEMBL12943462

CNNCc1cc2cccc(C)c2c(=O)[nH]1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 1/20 0.46
▸ PARP1 P09874 3/20 0.42
▸ DAO P14920 1/20 0.38
▸ DDO Q99489 1/20 0.38
▸ PDE3B Q13370 1/20 0.35
▸ PDE3A Q14432 1/20 0.35
▸ RXFP1 Q9HBX9 1/20 0.35
▸ BRD4 O60885 4/20 0.35
▸ KDM4E B2RXH2 3/20 0.34
▸ ALDH1A1 P00352 2/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ HSP90AA1 P07900 1/20 0.34
▸ HSP90AB1 P08238 1/20 0.34
▸ GAA P10253 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ THRB P10828 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ BLM P54132 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ SAE1 Q9UBE0 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6645443 0.73 CYP1A2 (0.56) CYP1A2PARP1DAODDOPDE3B
SCHEMBL13064936 0.66 ALDH1A1 (0.57) CYP1A2KDM4EALDH1A1MEN1GAA
SCHEMBL26287906 0.64 CYP1A2 (1.00) CYP1A2PARP1DAODDOPDE3B
SCHEMBL6649111 0.64 PDGFRB (0.47) CYP1A2PARP1KDM4EALDH1A1
SCHEMBL4769876 0.63 KDM4E (0.55) CYP1A2PARP1RXFP1KDM4EALDH1A1
SCHEMBL168637 0.62 JAK2 (0.61) CYP1A2PARP1DAODDOBRD4
SCHEMBL29914966 0.62 PARP1 (0.54) CYP1A2PARP1DAODDOBRD4
SCHEMBL4279145 0.60 MEN1 (0.46) CYP1A2PARP1DAODDOKDM4E
SCHEMBL598921 0.60 CYP1A2 (0.52) CYP1A2KDM4EALDH1A1MEN1HPGD
SCHEMBL30838794 0.59 PARP1 (1.00) PARP1KDM4EALDH1A1GAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3441392-B1 A PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION INTELLIKINE LLC (US) 2021-12-15 — — EP disclosed
WO-2011008302-A1 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS AND METHODS INTELLIKINE, INC. (US) 2011-01-20 — — WO disclosed
Send feedback